Unknown

Dataset Information

0

A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.


ABSTRACT: Although severe immune dysregulation is an established risk factor for non-Hodgkin lymphoma (NHL), the importance of subclinical immunologic effects is unclear. We compared baseline serum levels of 67 immune and inflammation markers between 301 patients with NHL diagnosed 5+ years after blood collection and 301 control patients within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. We observed associations with NHL for elevated B-cell-attracting chemokine 1 (BCA-1; fourth quartile vs first: odds ratio [OR], 2.7; 95% confidence interval [CI], 1.7-4.2; Ptrend = 1.0 × 10(-6)), soluble tumor necrosis factor receptor 2 (sTNFR2; OR, 3.4; 95% CI, 2.0-5.8; Ptrend = 1.1 × 10(-6)), and soluble vascular endothelial growth factor receptor 2 (sVEGFR2; OR, 2.3; 95% CI, 1.4-3.9; Ptrend = .0005) that remained significant after Bonferroni correction, simultaneous model adjustment, and restriction to cases diagnosed 8 to 13 years after blood collection. Associations with other markers were observed, although none remained associated with NHL after adjustment for BCA-1, sTNFR2, and sVEGFR2. Our findings suggest that circulating BCA-1, sTNFR2, and sVEGFR2 are associated with NHL risk well in advance of diagnosis. Additional research is needed to replicate these findings and elucidate the underlying biologic mechanisms.

SUBMITTER: Purdue MP 

PROVIDER: S-EPMC3739038 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.

Purdue Mark P MP   Hofmann Jonathan N JN   Kemp Troy J TJ   Chaturvedi Anil K AK   Lan Qing Q   Park Ju-Hyun JH   Pfeiffer Ruth M RM   Hildesheim Allan A   Pinto Ligia A LA   Rothman Nathaniel N  

Blood 20130627 6


Although severe immune dysregulation is an established risk factor for non-Hodgkin lymphoma (NHL), the importance of subclinical immunologic effects is unclear. We compared baseline serum levels of 67 immune and inflammation markers between 301 patients with NHL diagnosed 5+ years after blood collection and 301 control patients within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. We observed associations with NHL for elevated B-cell-attracting chemokine 1 (BCA-1; fourth qua  ...[more]

Similar Datasets

| S-EPMC6400235 | biostudies-literature
| S-EPMC3138883 | biostudies-literature
| S-EPMC6165815 | biostudies-literature
| S-EPMC2756127 | biostudies-literature
| S-EPMC3948172 | biostudies-literature
| S-EPMC2234796 | biostudies-literature
| S-EPMC5869109 | biostudies-literature
| S-EPMC2651009 | biostudies-literature
| S-EPMC4055650 | biostudies-literature
| S-EPMC3205981 | biostudies-literature